Literature DB >> 1730482

Enhancement of mucosal antibody responses to Salmonella typhimurium and the microbial hapten phosphorylcholine in mice with X-linked immunodeficiency by B-cell precursors from the peritoneal cavity.

S S Pecquet1, C Ehrat, P B Ernst.   

Abstract

The observation that approximately half of the B cells in the murine intestinal lamina propria are derived from peritoneal CD5 B-cell precursors raises the question of their contribution to mucosal protection. Using mice with X-linked immunodeficiency which are deficient in CD5+ B cells, we showed that they mount little serum and virtually no intestinal immunoglobulin M (IgM), IgG, and IgA antibody responses following oral inoculation with live Salmonella typhimurium. Nonresponsive Xid mice were reconstituted with responsive CBA/Ca donor cell preparations which were constitutively enriched or depleted of CD5 B-cell precursors. Reconstitution of irradiated Xid mice with CD5 B-cell-deficient bone marrow from CBA/Ca donors marginally improved IgM responses in the intestinal mucosa but had no effect on IgG or IgA in response to oral immunization with live S. typhimurium. Whenever Xid mice were reconstituted with donor cells from the peritoneal cavity, which are enriched for CD5 B-cell precursors, strong IgA and in some cases IgG responses in the intestinal mucosa were stimulated in response to oral immunization. When mucosal and serum antibody responses were compared, the peritoneal donor cells again reinstated maximal serum antibody responses to S. typhimurium. Serum and mucosal responses to the bacterial hapten phosphorylcholine could be induced in Xid mice after immunization with S. typhimurium or hapten-carrier conjugates but only following reconstitution with donor cells containing CD5 B-cell precursors. These observations suggest that different lymphoid compartments are enriched for regulatory or effector cells which vary in their contributions to the mucosal antibody response against epitopes on S. typhimurium.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1730482      PMCID: PMC257656          DOI: 10.1128/iai.60.2.503-509.1992

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  35 in total

1.  All T15 Id-positive antibodies (but not the majority of VHT15+ antibodies) are produced by peritoneal CD5+ B lymphocytes.

Authors:  H Masmoudi; T Mota-Santos; F Huetz; A Coutinho; P A Cazenave
Journal:  Int Immunol       Date:  1990       Impact factor: 4.823

2.  A role for isotype-specific binding factors in the regulation of IgA- and IgG-specific responses by the anti/contrasuppressor T cell circuit.

Authors:  P B Ernst; S T Lee; J Maeba; J Bienenstock; A M Stanisz; F Paraskevas
Journal:  J Immunol       Date:  1989-09-01       Impact factor: 5.422

3.  The Ly-1 B cell lineage.

Authors:  L A Herzenberg; A M Stall; P A Lalor; C Sidman; W A Moore; D R Parks; L A Herzenberg
Journal:  Immunol Rev       Date:  1986-10       Impact factor: 12.988

4.  Immunoglobulin VH gene expression in Ly-1+ and conventional B lymphocytes.

Authors:  L Andrade; A A Freitas; F Huetz; P Poncet; A Coutinho
Journal:  Eur J Immunol       Date:  1989-06       Impact factor: 5.532

5.  Differential adherence of epithelium overlying gut-associated lymphoid tissue. An ultrastructural study.

Authors:  J Pappo; H J Steger; R L Owen
Journal:  Lab Invest       Date:  1988-06       Impact factor: 5.662

6.  A novel mechanism for the selection of isotype-specific antibody responses: the role of intestinal T cells in the regulation of IgA synthesis by the anti-suppressor circuit.

Authors:  P B Ernst; J Maeba; S I Lee; F Paraskevas
Journal:  Immunology       Date:  1988-09       Impact factor: 7.397

7.  Many of the IgA producing plasma cells in murine gut are derived from self-replenishing precursors in the peritoneal cavity.

Authors:  F G Kroese; E C Butcher; A M Stall; P A Lalor; S Adams; L A Herzenberg
Journal:  Int Immunol       Date:  1989       Impact factor: 4.823

8.  Cellular kinetics of the intestinal immune response to cholera toxoid in rats.

Authors:  N F Pierce; J L Gowans
Journal:  J Exp Med       Date:  1975-12-01       Impact factor: 14.307

9.  Antibody-defective, genetically susceptible CBA/N mice have an altered Salmonella typhimurium-specific B cell repertoire.

Authors:  L W Duran; E S Metcalf
Journal:  J Exp Med       Date:  1987-01-01       Impact factor: 14.307

10.  Isotype-specific immunoregulation. Evidence for a distinct subset of T contrasuppressor cells for IgA responses in murine Peyer's patches.

Authors:  I Suzuki; K Kitamura; H Kiyono; T Kurita; D R Green; J R McGhee
Journal:  J Exp Med       Date:  1986-08-01       Impact factor: 14.307

View more
  14 in total

Review 1.  B cell superantigens: a microbe's answer to innate-like B cells and natural antibodies.

Authors:  Carl S Goodyear; Gregg J Silverman
Journal:  Springer Semin Immunopathol       Date:  2005-03

Review 2.  Inherent specificities in natural antibodies: a key to immune defense against pathogen invasion.

Authors:  Nicole Baumgarth; James W Tung; Leonore A Herzenberg
Journal:  Springer Semin Immunopathol       Date:  2005-01-05

3.  Human C-reactive protein is protective against fatal Salmonella enterica serovar typhimurium infection in transgenic mice.

Authors:  A J Szalai; J L VanCott; J R McGhee; J E Volanakis; W H Benjamin
Journal:  Infect Immun       Date:  2000-10       Impact factor: 3.441

4.  Protective immunity against Salmonella typhimurium elicited in mice by oral vaccination with phosphorylcholine encapsulated in poly(DL-lactide-co-glycolide) microspheres.

Authors:  K Allaoui-Attarki; S Pecquet; E Fattal; S Trollé; E Chachaty; P Couvreur; A Andremont
Journal:  Infect Immun       Date:  1997-03       Impact factor: 3.441

5.  Presence of activated B-1 cells in chronic inflamed gingival tissue.

Authors:  M Aramaki; T Nagasawa; T Koseki; I Ishikawa
Journal:  J Clin Immunol       Date:  1998-11       Impact factor: 8.317

6.  Recipient age determines the success of intraperitoneal transplantation of peritoneal cavity B cells.

Authors:  P Julius; M Kaga; Y Palmer; V Vyas; L Prior; D Delice; J Riggs
Journal:  Immunology       Date:  1997-07       Impact factor: 7.397

7.  Rapid restoration of B-cell function in XID mice by intravenous transfer of peritoneal cavity B cells.

Authors:  L Prior; S Pierson; R T Woodland; J Riggs
Journal:  Immunology       Date:  1994-10       Impact factor: 7.397

8.  Intraperitoneal immunization of human subjects with tetanus toxoid induces specific antibody-secreting cells in the peritoneal cavity and in the circulation, but fails to elicit a secretory IgA response.

Authors:  C Lue; A W van den Wall Bake; S J Prince; B A Julian; M L Tseng; J Radl; C O Elson; J Mestecky
Journal:  Clin Exp Immunol       Date:  1994-05       Impact factor: 4.330

9.  Evaluation of formalin-inactivated Clostridium difficile vaccines administered by parenteral and mucosal routes of immunization in hamsters.

Authors:  J F Torres; D M Lyerly; J E Hill; T P Monath
Journal:  Infect Immun       Date:  1995-12       Impact factor: 3.441

10.  Monoclonal immunoglobulin A derived from peritoneal B cells is encoded by both germ line and somatically mutated VH genes and is reactive with commensal bacteria.

Authors:  N A Bos; J C Bun; S H Popma; E R Cebra; G J Deenen; M J van der Cammen; F G Kroese; J J Cebra
Journal:  Infect Immun       Date:  1996-02       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.